Pharmaktiv acquired remaining 51% stake in Endogenix LLC from Gan & Lee Pharmaceuticals..
Pharmaktiv completed the acquisition of remaining 51% stake in Endogenix LLC from Gan & Lee Pharmaceuticals. (SHSE:603087) on June 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.74 CNY | +0.91% |
|
-8.24% | -11.23% |
06-17 | Gan & Lee Pharmaceuticals.(SHSE:603087) added to SSE 180 Index | CI |
06-17 | Gan & Lee Pharmaceuticals.(SHSE:603087) added to Shanghai Stock Exchange 180 Value Index | CI |
1st Jan change | Capi. | |
---|---|---|
-11.23% | 3.81B | |
+2.08% | 95.18B | |
-0.13% | 37.55B | |
-10.25% | 33.75B | |
+77.76% | 28.2B | |
-14.27% | 15.63B | |
-2.79% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |